Skip to main content
Amphastar Pharmaceuticals, Inc. logo

Amphastar Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · AMPH ISIN · US03209R1032 LEI · 54930055TH0ZLSAQMJ38 US Manufacturing
Open in API
Filings indexed 918 across all filing types
Latest filing 2015-07-22 Director's Dealing
Country US United States of America
Listing US AMPH

About Amphastar Pharmaceuticals, Inc.

https://amphastar.com/

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing technically challenging medications. Its portfolio includes generic and proprietary injectable, intranasal, and inhalation products. The company specializes in complex medications such as biologics derived from living cells, proteins, and interchangeable biosimilars. Amphastar also develops innovative drug delivery systems and proprietary technological platforms for various routes of administration.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2015-07-22 English
Regulatory Filings 2015
Regulatory Filings
2015-07-20 English
Regulatory Filings 2015
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-3. It is a formal communication related to a securities registration filing, not a financial report or detailed disclosure document itself. The text is short (2875 characters) and does not contain financial data or report content but is an administrative request related to a filing. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2015-07-14 English
Regulatory Filings 2015
Regulatory Filings
2015-07-10 English
FORM 4 SUBMISSION
Director's Dealing
2015-07-07 English
FORM S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as equity incentive plans. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an earnings release or management discussion. The document is a regulatory filing related to securities registration and compliance with the Securities Act of 1933. It contains legal and procedural information about the registration of shares under an equity incentive plan, including indemnification provisions and incorporation by reference of other filings. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other categories.
2015-07-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.